1 |
Muller, B. 1991. Pharmacology of thromboxane A2, prostacyclin and other eicosanoids in the cardiovascular system. Therapie 46, 217-221.
|
2 |
Nishio, S., Matsuura, H., Kanai, N., Fukatsu, Y., Hirano, T., Nishikawa, N., Kameoka, K. and Umetsu, T. 1988. The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species. Jpn. J. Pharmacol. 47, 1-10.
DOI
|
3 |
Sakai, A., Hori, T., Okuda, T., Matsubara, T., Saitoh, K., Yajima, M. and Nishio, S. 1989. Effect of TRK-100, a prostacyclin analogue, on endotoxin-induced enhancement of blood coagulation in rats. Jpn. J. Pharmacol. 51, 450-454.
DOI
|
4 |
Zhao, N., Liu, Y. Y., Wang, F., Hu, B. H., Sun, K., Chang, X., Pan, C. S., Fan, J. Y., Wei, X. H., Li, X., Wang, C. S., Guo, Z. X. and Han, J. Y. 2010. Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats. Am. J. Physiol. Heart Circ. Physiol. 298, H1166-1176.
DOI
|
5 |
Grant, S. M. and Goa, K. L. 1992. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs 43, 889-924.
DOI
|
6 |
Horie, Y., Han, J. Y., Mori, S., Konishi, M., Kajihara, M., Kaneko, T., Yamagishi, Y., Kato, S., Ishii, H. and Hibi, T. 2005. Herbal cardiotonic pills prevent gut ischemia/reperfusion-induced hepatic microvascular dysfunction in rats fed ethanol chronically. World J. Gastroenterol. 11, 511-515.
DOI
|
7 |
Virgolini, I., Fitscha, P., Linet, O. I., O’Grady, J. and Sinzinger, H. 1990. A double blind placebo controlled trial of intravenous prostacyclin (PGI2) in 108 patients with ischaemic peripheral vascular disease. Prostaglandins 39, 657- 664.
DOI
|
8 |
Wei, X. H., Liu, Y. Y., Li, Q., Yan, L., Hu, B. H., Pan, C. S., Li, Z. X., Chang, X., Fan, J. Y., Zhao, N., Sun, K., Huang, P., Wang, C. S., Fan, T. P. and Han, J. Y. 2013. Treatment with cardiotonic pills ((R)) after ischemia-reperfusion ameliorates myocardial fibrosis in rats. Microcirculation 20, 17-29.
DOI
|
9 |
Fowkes, F. G., Housley, E., Cawood, E. H., Macintyre, C. C., Ruckley, C. V. and Prescott, R. J. 1991. Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int. J. Epidemiol. 20, 384-392.
DOI
|
10 |
Nony, P., Ffrench, P., Girard, P., Delair, S., Azoulay, S., Girre, J. P., Dechavanne, M. and Boissel, J. P. 1996. Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects. Can. J. Physiol. Pharmacol. 74, 887-893.
DOI
|
11 |
Gresele, P., Momi, S. and Falcinelli, E. 2011. Anti-platelet therapy: phosphodiesterase inhibitors. Br. J. Clin. Pharmacol. 72, 634-646.
DOI
|
12 |
Kim, E. 2015. Molecular cloning and characterization of Izumo1 gene from bovine testis. J. Anim. Sci. Technol. 57, 16.
DOI
|
13 |
Lee, S. R., Kim, H. O. and Yoo, C. H. 2011. Clinical outcomes of TS-1 chemotherapy for advanced and recurrent gastric cancer. J. Kor. Surg. Soc. 81, 163-168.
DOI
|